Amicus Therapeutics, Inc.

FOLDDelisted Apr 27, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001178879

SEC filings (opens in a new tab)

Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Amicus Therapeutics, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of FOLD: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Of which not filed for Q1 2024	Q1 2024	Change
Holders	229	1	254	+26
Shares	319.0M	710.6K	321.9M	+3.65M (+1.1%)
Value	$4.53B	$9.95M	$3.79B	−$723.6M (−16.0%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (44)

Institutions that held Amicus Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to FOLD in Q1 2024
Institution	Shares	Value	% of portfolio
Standard Life Aberdeen plc	1,622,399	$19.1M	0.04%
Granite Investment Partners, LLC	918,834	$10.8M	0.41%
M&G Plc	665,723	$7.99M	0.05%
Qube Research & Technologies Ltd	556,363	$6.55M	0.01%
Osterweis Capital Management Inc	484,060	$5.70M	0.33%
Squarepoint Ops LLC	251,106	$2.96M	0.01%
Parkman Healthcare Partners LLC	226,723	$2.67M	0.33%
Aquatic Capital Management LLC	112,900	$1.33M	0.04%
Millennium Management LLC	101,899	$1.20M	0.00%
Schonfeld Strategic Advisors LLC	77,976	$918.6K	0.01%
Capital Fund Management S.A.	69,431	$817.9K	0.01%
Y-Intercept (Hong Kong) Ltd	67,241	$792.1K	0.06%
Eisler Capital (US) LLC	60,383	$711.3K	0.24%
Soleus Capital Management, L.P.	57,966	$682.8K	0.06%
Bayesian Capital Management, LP	50,200	$591.4K	0.06%
Sherbrooke Park Advisers LLC	46,802	$551.3K	0.11%
Dynamic Technology Lab Private Ltd	43,998	$518.0K	0.06%
Point72 (DIFC) Ltd	43,178	$508.6K	0.04%
Mesirow Institutional Investment Management, Inc.	31,599	$372.2K	0.03%
HSBC Holdings PLC	30,464	$358.9K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	29,469	$347.1K	0.09%
SG Americas Securities, LLC	24,668	$291.0K	0.00%
Two Sigma Advisers, LP	24,576	$289.5K	0.00%
Walleye Capital LLC	22,344	$263.2K	0.00%
Verition Fund Management LLC	18,767	$221.1K	0.00%
Capula Management Ltd	17,000	$200.3K	0.01%
Deerfield Management Company, L.P. (Series C)	16,489	$194.2K	0.00%
Cerity Partners LLC	16,158	$190.3K	0.00%
Truist Financial Corp	14,296	$168.4K	0.00%
Aigen Investment Management, LP	12,034	$141.8K	0.03%
MML Investors Services, LLC	10,520	$124.0K	0.00%
Torno Capital, LLC	4,000	$47.1K	0.01%
Pacer Advisors, Inc.	3,468	$40.9K	0.00%
State of Wyoming	3,193	$37.6K	0.01%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	2,700	$31.8K	0.00%
CIBC Private Wealth Group, LLC	1,959	$23.0K	0.00%
Catalyst Funds Management Pty Ltd	1,800	$21.2K	0.01%
Meeder Asset Management Inc	374	$4.41K	0.00%
JFS Wealth Advisors, LLC	282	$3.32K	0.00%
Continuum Advisory, LLC	141	$1.34K	0.00%
Geneos Wealth Management Inc.	65	$766	0.00%
EverSource Wealth Advisors, LLC	57	$570	0.00%
Rothschild Investment LLC	30	$353	0.00%
Federated Hermes, Inc.	28	$330	0.00%

Sold out (18)

Institutions that held Amicus Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of FOLD in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Balyasny Asset Management LLC	1,556,540	$22.1M
Finepoint Capital LP	1,489,025	$21.1M
Cutter Capital Management, LP	947,418	$13.4M
Caption Management, LLC	299,500	$4.25M
Algert Global LLC	184,540	$2.62M
Twinbeech Capital LP	149,387	$2.12M
Connor, Clark & Lunn Investment Management Ltd.	110,665	$1.57M
Natixis	47,250	$670.5K
Group One Trading, L.P.	33,514	$475.6K
Jefferies Financial Group Inc.	29,494	$418.5K
Quantbot Technologies LP	19,000	$269.6K
Cipher Capital LP	16,162	$229.3K
Old Well Partners, LLC	12,700	$180.2K
Beirne Wealth Consulting Services, LLC	10,933	$155.1K
Calton & Associates, Inc.	10,011	$142.1K
Pathway Financial Advisers, LLC	1,575	$22.3K
Ronald Blue Trust, Inc.	240	$3.00K
Able Wealth Management LLC	117	$1.66K

Not filed for Q1 2024 yet (1)

Institutions that held Amicus Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FOLD in Q4 2023 that haven't filed for Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
M&G Investment Management Ltd	710,557	$9.95M